glp-1 gip and glucagon GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Triple GLP-1 / GIP /

Lilly is attacking with dual agonists, triple agonists, and oral small-molecule GLP-1

However, 5 to 10% of patients with prediabetes turn to type 2 DM per year and there is not a pharmacological solution without side effects in the long term

Your healthcare team can work together to optimize both your overall health and oral health outcomes

An updated definition of stroke for the 21st century a statement for healthcare professionals from the American Heart Association/American Stroke Association

The goal is to make sure patients understand the warning signs of NAION and know when to seek urgent eye care

Less common side effects Beyond the big three of bloating, nausea, and bowel changes, several less common side effects deserve mention